Detalhe da pesquisa
1.
Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples.
Int J Mol Sci
; 25(10)2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791138
2.
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
Metabolomics
; 19(7): 60, 2023 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344702
3.
Untargeted Metabolomics by Liquid Chromatography-Mass Spectrometry in Biomedical Research.
Methods Mol Biol
; 2571: 57-69, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152150
4.
Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach.
Mol Oncol
; 16(14): 2658-2671, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338693
5.
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
Cancers (Basel)
; 13(1)2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466323
6.
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.
Clin Transl Med
; 14(1): e1541, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239072